Infection
Terms
undefined, object
copy deck
- Infection
- Invasion of the body tissue by a microorganism and their proliferation there
- Assymptomatic
- Microorganism produces no clinical evidence of disease
- Disease
- A detectable alteration in normal tissue function
- Chain of Infection
-
-Infectious agent: microorganism
-Reservoir: the normal location for the pathogen
-Portal of exit from the reservoir:
-Mode of transportation: Direct (physical) and indirect (ingestion) contact, air and dust, fomites, arthropod (bites) and accidental (needle sticks) inoculation.
-Portal of entry: GI tract, blood and blood derivatives, respiratory tract, wounds
-Susceptible host: - Natural Immunity
-
-Nonspecific response to a foreign invader
-Physical barriers: skin, mucus membranes, chemical - Acquired Immunity
-
-Specific response to a foreign invader
-Involves the immune system responding to a specific foreign antigen
-Includes humoral and cellular response
-Acitve or Passive - Acitve Acquired Immunity
-
-Antibodies produced in the body in response to an infection
-Long lasting
-Natural or artificial - Natural Active Acquired Immunity
-
-Formed in the presence of an active infection: chicken pox, hep A
-Lifelong - Artificial Active Acquired Immunity
-
-Immunized with vaccines or toxoids and stimulates antibody production
-Lifelong though may require a booster - Passive Acquired Immunity
-
-Antibodies are produced by another source
-Short acting
-Natural (breast milk) or artificial (hep A) - Natural Passive Acquired Immunity
- -Antibodies transferred naturally from immune mother to infant at birth or through breast milk
- Artificial Passive Acquired Immunity
-
-Immune serum from another source transferred by injection
-Exp: hep A - Immunizations
-
-Important to health promotion
-Many adults not adequately immunized
-Adult immunizations include:
*hep B
*Influenza
*Diptheria/Tetanus
*Measles, Mumps, Rubella (MMR) - Inflammmatory Response
-
-Chemical medications are released in response to tissue injurt or organisms to:
*Control blood loss
*Wall of organism
*Activate phagocytes
*Promote scar formation and tissue regeneration - Inflammatory Response
-
-Local: redness, swelling, pain, heat, and loss of function
-Systemic: increased body temp, fatigue, increased WBC, and swollen lymph nodes - Contact Transmission
-
-Prevent transmission of organism through direct or indirect contact
-Herpes, Diptheria, Staph, Hep A, and wound infection
-Private room
-Glove and gown worn
-Door can be open
-Direct: skin-to-skin
-Indierct: skin-to-object (MRSA, lice, scabbies) - Droplet Transmission
-
-Prevent transmission of large molecular organisms (>5microns)
-Diptheria, Pertussis, Strept throat, Scarlet fever, Meningitis, Rubella, Influenza, SARS
-Private room
-3ft distance or wear mask w/glasses
-Door allowed to be open
-Coughing, sneezing, talking droplets can travel up to 3 feet - Responsibilities of the CDC
-
-Prevent the transmission of communicable diseases
-Collect data
-Updating recommendations
-Publishes the Mortality and Morbidity Report
-Disease Surveillance
-Research - Cardinal signs of inflammation
-
-Redness
-Pain
-Swelling
-Heat
-Loss of function - Four stages of the infectious process
-
-Incubation: time between contact and onset of signs and symptoms
-Prodromal period: the period between the earliest symptoms and the onset of a rash or fever
-Illness period: the onset of the disease
-Convalescent period: recovery phas - Airborne Transmission
-
-To prevent transmission of small particles (<5 microns)
-Negative air pressure room
-Door closed
Particulate respiratory mask tight fit (orange) - Anti-Infective Agents
-
-Treatment and prophylaxis of variuos bacterial agents
-Mechanisms of action:
*inhibits cell wall synthesis
*alters plasma membranes
*inhibits protein synthesis
*inhibits synthesis of essential metabolites
-Mode of action:
*bactericidal or bacteristatic (inhibit new growth)
*not active against viruses and fungi
-Spectrum:
*broad or narrow
*divided into categories depending on the chemical similarities and anitmicrobial spectrum - Pharmacological Management
-
-Antibacterial:
*broadest group
-Antiviral:
*inhibits viral DNA replication
-Antifungal:
*inhibits mycotic (fungal) infections - Toxic Shock Syndrome
-
-Caused by a toxin of Staph A. when in the bloodstream in susceptible individuals
-55% of menstrating women
-Associated with tampon use - S/S and Tx of Toxic Shock Syndrom
-
-Sudden fever
-Decreased b/p
-Headache
-Diarrhea
-Red rash on palms of hands and soles of feet
-Fluids and antibiotics - Stapphylococcal
-
-Normal flora of skin and respiratory tract
-Usually nonpathogenic but can cause serious infections
-Cause of nosocomial UTI and endocardititis
-Pathogenic staph in 30% of health people
-Contact precautions - Streptococcal
-
-Virulent and contagious
-Causes of Scarlet fever, strept throat, and impetigo
-GAS - Coccidioidomycosis
-
-Fungal infection
-Indiginous to San Joaquin Valley
-Valley Fever
-Inhalation of spores into lungs after rainfall
-Rainfall increases growth
-Sunlight inhibits growth
-Dx is made by skin test
-Tx is Amphotercin B
-Very toxic
-Hypersensitivity reactions
-Phlebitis
-Renal changes
-Hypokalemia
-Standard precautions - Clostridium Difficele
-
-Anarobic Spore forming organism
-Common nosocomial causing diarrhea
-Easily spread
-Usually starts within 48 hours after antibiotic therapy started
-Vancomycin: drug of choice
-Contact precautions - MRSA
-
-Methicillin Resistant Staph
-Contagious form of staph not susceptible to penicillin
-Caused by misuse of antibiotics
-Requires isolation until 2 negative cultures
-Vancomycin drug of choice
-Contact isolation - VRE
-
-Vancomycin Resistant Enterococcus
-Gram positive
-Normal Flora of GI tract
-20 fold increase since 1989
-VRE may serve as a reservoir of genes coded for vanco resistance that can be transferred to staph
-Penicillin used but no cure - Lyme Disease
-
-Multi-system disorder caused by Borrelia Burgdorferi organism carried by the TICK
-Identified in the 1970s
-Progresses in stages
-Starts with skin lesion and progresses to cardiac and neurological abnormalities - Tuberculosis
-
-Droplet nuclei gains into upper lobes of lungs and multiples
-Spread by cough, sneeze, speaking
-4-5 weeks without treatment the germs are numerous and spreads to the blood stream
-Immune system is stimulated
-Droplet isolation - S/S Tuberculosis and Screening
-
-Fatigue
-Weight loss
-Anorexia
-Low grade temperature, night sweats, long lasting cough
-Screening:
*Intradermal Mantoux Test
*Purified Protein Derivative (PPD)
*Read in 48 hours
*Those exposed wil have a + reaction:
~>5mm + HIV + or recent close contact
~>10mm + if from high risk group
~>15mm + for all others
*+ skin test does not mean active TB
*Sputum is the only definitive Dx
*AFB sputum obtained in arm, need 3 consecutive specimens
*Chest X-Ray used for screening only - Tuberculosis Classification
-
-0 = no TB
-1 = TB exposure, no disease
-2 = TB exposure, and + PPD
-3 = TB disease, + sputum, + skin
-4 = History of TB disease
-5 = TB suspect (3 months) - Tuberculosis Treatment
-
-Medications: Rifampin, Isoniazid
-Chemotherapy (medications)
-6 months to 1 year
-2 months of of daily INH, RIF, ENH
-4 months twice daily
-up to 1 year of 2 drugs twice daily
-Reduces the risk of developing active TB
-Recent skin test converter
-Pediatric with know close contact
-High risk
-6 months of INH only - Tuberculosis Medications
-
-Isoniazid (INH):
*Side effects: peripheral neuritis, hepatoxicity, hypersensitivity, and optic neuritis
-Rifampin (RIF):
*Side effects: hepatitis, febrile reaction, GI disturbance, peripheral neuropathy, and hypersensitivity
-Ethambutol:
*Side effects: skin rash, GI disturbances, malaise, peripheral neuritis, optic neuritis
-Streptomycin:
*Side effects: audiotoxicity, nephrotoxicity, hypersensitivity
-2nd line drugs:
*Ethionamide
*Capreomycin
*Kanamycin
*Pyrazinamide
*Para-aminosalicylic acid (PAS) - Hepatitis
-
-Infects the liver
-Many people do not have and S/S but may have serious or fatal complications
like cirrhosis, liver CA, chronic liver disease
-5-10% become carriers
-5 types - Types of Hepatitis
-
-Hep A: fecal/oral
-Hep B: serum
-Hep C: non A non B
-Hep D: delta
-Hep E: enteric - Heptatis A
-
-Fecal/oral
-Ingestion of contaminated foods
-poor sanitation
-Day care centers
-Incubation: 15-19 days
-Vaccine available - Hepatitis B
-
-Blood and body fluids
-Sexually transmitted
-Needles
-Incubation: 28-165 days
-Vaccine available
-10% carrier status - Hepatitis C
-
-Non A, Non B
-Needle stick
-Blood transfusion
-Mother to baby
-Incubation: 15-120 days
-S/S can occur up to 30 years after exposure
-No Vaccine - Hepatitis D
-
-Delta
-Needle sticks
-Sexually transmitted
-Must have Hep B to get Hep D
-Incubation: 21-140 days
-High carrier rate
-Vaccine for Hep B - Hepatitis E
-
-Enteric
-Poor santitation
-Water
-Not seen in the US
-Incubation: 15-65
-Unknown immunity - Hepatitis Protection
-
-Blood borne pathogen
-Universal precautions
-Hep B vaccine - Causative Organism
- The types of organism that cause infection are bacteria, rickettsiae, viruses, protozoa, fungi, helminths
- Reservoir
- Any person, plant, animal, substance, or location that provides nourishment for microorganisms and enables further dispersal of the organism
- Mode of Exit
- The organism must have a mode of exit from the reservoir. Organisms exit through the respiratory tract, the GI tract, the genitourinary tract and the blood
- Route of Transmission
- Is necessary to connect the infectious source with its new host. Organisms may be tramsmitted through sexual contact, skin-to-skin contact, percutaneous injection, or infectious particles carried through the air
- Carrier
- A person who carries, or transmits an organism and who does not have apparent signs and symptoms of infection
- Susceptible Host
- For infection to occur a host must be susceptible (not possessing immunity to a particlular pathogen)
- Portal of Entry
- Is needed for the microorganism to gain access to the host
- Colonization
- Microorganisms present in or on a host, without host interference or interaction and without eliciting symptoms in the host
- Infectious Disease
- The state in which the infected host displays a decline in wellness due to the infection
- Microbiology Report
-
Usually shows:
*the smear and stain
*the culture and organism identification
*the antimicrobial susceptibility (sensitivity) - CDC and OSHA
-
-CDC goal: disease reduction
-OSHA goal: reduction of risk exposure
-CDC Regulations: optional
-OSHA Regulations: mandatory